TY - JOUR PY - 2017// TI - Risk of falls associated with antiepileptic drug use in ambulatory elderly populations: A systematic review JO - Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC A1 - Maximos, Mira A1 - Chang, Feng A1 - Patel, Tejal SP - 101 EP - 111 VL - 150 IS - 2 N2 - BACKGROUND: Falls are a major cause of morbidity and mortality in older adults. About a third of those aged 65 years or older fall at least once each year, which can result in hospitalizations, hip fractures and nursing home admissions that incur high costs to individuals, families and society. The objective of this clinical review was to assess the risk of falls in ambulatory older adults who take antiepileptic drugs, medications that can increase fall risk and decrease bone density.

METHODS: PubMed, EMBASE, MEDLINE and the Cochrane Library electronic databases were searched from inception to July 2014. Case-control, quasi-experimental and observational design studies published in English that assessed quantifiable fall risk associated with antiepileptic drug use in ambulatory patient populations with a mean or median age of 65 years or older were eligible for inclusion. One author screened all titles and abstracts from the initial search. Two authors independently reviewed and abstracted data from full-text articles that met eligibility criteria.

RESULTS: Searches yielded 399 unique articles, of which 7 met inclusion criteria-4 prospective or longitudinal cohort studies, 1 cohort study with a nested case-control, 1 cross-sectional survey and 1 retrospective cross-sectional database analysis. Studies that calculated the relative risk of falls associated with antiepileptic drug use reported a range of 1.29 to 1.62. Studies that reported odds ratios of falls associated with antiepileptic drug use ranged from 1.75 to 6.2 for 1 fall or at least 1 fall and from 2.56 to 7.1 for more frequent falls.

DISCUSSION: Health care professionals should monitor older adults while they take antiepileptic drugs to balance the need for such pharmacotherapy against an increased risk of falling and injuries from falls.

Language: en

LA - en SN - 1715-1635 UR - http://dx.doi.org/10.1177/1715163517690744 ID - ref1 ER -